Nova Patents
ATE399151T1

2-ethyl and 2-ethylidene-19-nor-vitamin d compounds

Abstract

Biologically active 19-nor vitamin D analogs substituted at C-2 in the A-ring with an ethylidene or an ethyl group. These compounds have preferential activity on mobilizing calcium from bone and either high or normal intestinal calcium transport activity which allows their in vivo administration for the treatment of metabolic bone diseases where bone loss is a major concern. These compounds are also characterized by high cell differentiation activity.

Term

Term ended

Projected expiry passed 31 May 2021, 5.3 years ago.

  1. Priority
  2. Filed
  3. Published
  4. Projected expiry
  5. Today

33 members in 15 offices

This recordMember, by publication datePriority claim5 more offices are in the list below

Priority claims1

Priority claims
DocumentOfficeKindDate
20819900United States of AmericaP

Members33

Family members, oldest first
DocumentOfficeKind
CA2410880A1CanadaA1
WO0192221A1World Intellectual Property Organization (WIPO)A1
AU6527201AAustraliaA
US2003013691A1United States of AmericaA1
EP1286962A1European Patent Office (EPO)A1
MXPA02011820AMexicoA
BR0111173ABrazilA
IL152942A0IsraelA0
IL152942D0IsraelD0
JP2004501114AJapanA
NZ522909ANew ZealandA
US6806262B2United States of AmericaB2
US2005043281A1United States of AmericaA1
EP1524264A2European Patent Office (EPO)A2
US2005282789A1United States of AmericaA1
US6992074B2United States of AmericaB2
AU2001265272B2AustraliaB2
US7141558B2United States of AmericaB2
US2007088008A1United States of AmericaA1
IL152942AIsraelA
US7300925B2United States of AmericaB2
JP4022141B2JapanB2
US2008032956A1United States of AmericaA1
EP1286962B1European Patent Office (EPO)B1
AT399151TAustriaT
ATE399151T1This recordAustriaT1
PT1286962EPortugalE
DE60134549D1GermanyD1
DK1286962T3DenmarkT3
ES2309069T3SpainT3
US7468361B2United States of AmericaB2
CA2410880CCanadaC
EP1524264A3European Patent Office (EPO)A3